Reproductive Genetics Market is projected to reach the mark of $12.93 billion by 2030.

The global reproductive genetics market is poised to have substantial investment and growth as the demand for such testing escalates, reimbursement improves, and the technology expands to additional, novel applications.

There has been steady progress in the demand for various methods of reproductive genetic testing. For instance, there has been a global explosion in the utilization of additional non-invasive prenatal testing (NIPT) and the continuous expansion of upstream preconception testing (PGD/PGS) and downstream neonatal screening and genetic disorder testing. Further, there has been a rise in the availability of next-generation technologies and panels that allow the screening of genetic disorders at an early stage in the fetus during pregnancy. However, some of these tests are often an out-of-pocket expense for patients, but the demand for genetic information, declining cost of sequencing, and rise in mixed-ethnicity population is expected to propel the growth of the market.

In 2020, the global reproductive genetics market generated $4.40 billion and is projected to reach the mark of $12.93 billion by 2030.

The global reproductive genetics market consists of numerous large-and small-scale manufacturers and service providers. Presently, with the increasing rate of molecular advancements and the rise in the adoption of genetic tests, there has been an expansion of opportunities for the reproductive genetics market. Some of the strategies opted by the key players within the market are new product offerings, product approvals, partnerships and alliances, mergers and acquisitions, and business expansions.

In the five years (January 2017-February 2021), the market witnessed 23 product offerings, five product approvals, 16 partnerships and alliances, nine mergers and acquisitions, and five business expansions. The increasing awareness for genetic testing with an answer for genetic abnormalities caused has majorly attributed to the growing prominence for reproductive genetic testing.

On the basis of region, North America holds the largest share in the global reproductive genetics market due to improved healthcare infrastructure, rise in awareness, and improvised reimbursement policies in the region. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period.

Key Questions Answered in this Report:

•   What are the most common genetic causes of genetic defects at birth globally?
•   What are the emerging technologies that can take over the current technologies for genetic testing within the global reproductive genetics market?
•   How are the key market players performing research investments in the respective market?
•   What are the major strategies opted by the key players for advancing in the global reproductive genetics market?
•   What are the regulations pertaining to the reproductive genetics market among different regions and their impact on the respective market?
•   What are the initiatives implemented by different government bodies regulating the development and commercialization of reproductive genetic tests and associated platforms?
•   How has COVID-19 impacted the global reproductive genetics market?
•   How will the urgency of the pandemic influence the global reproductive genetics market?
•   What are the leading companies dominating the global reproductive genetics market?
•   What is the reimbursement scenario of the tests offered in the global reproductive genetics market?
•   Based on the procedure type, which global reproductive genetics market procedure type is anticipated to witness a massive rise in demand in the forecast period 2021-2030?
•   How is each segment of the global reproductive genetics market expected to grow during the forecast period, and what is the revenue expected to be generated by each of the segments by the end of 2030?
•   How is the global reproductive genetics industry anticipated to evolve during the forecast period 2021-2030?
•   What are the leading trends and consumer preferences witnessed in the global reproductive genetics market?

Request a Sample - https://bisresearch.com/requestsample?id=1112&type=download

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: • Industry Analysis ...

Hyperspectral Imaging Market Projections , Upcoming Trends Focus on Long-Term Impact of Covid-19 and Forecast By 2027

The global hyperspectral imaging market was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.The growth in the global hyperspectral imaging market is expected to be primarily driven by increased awareness of the technology in different sectors such as agriculture, healthcare, and mining. The hyperspectral imaging technology has great potential, and the market is anticipated to grow during the forecast period owing to the widespread applications of HSI, increasing investments for RD activities, increasing demand from military and defense sectors, increased food safety concerns, and increasing awareness regarding early diagnosis of diseases. COVID-19 Impact and Post-COVID-19 Scenario The COVID-19 pandemic had a debilitating impact on the global ecosystem. The pandemic led to a shutdown of production facilities, which do not come under essential goods, which led to a negative impact on se...

Market Research Reports

Search This Blog